CSIMarket
 
Pmgc Holdings Inc   (NASDAQ: ELAB)
 
Price: $5.2100 $-0.02 -0.382%
Day's High: $5.340000152587891 Week Perf: 0.39 %
Day's Low: $ 5.18 30 Day Perf: 444.98 %
Volume (M): 15,984 52 Wk High: $ 267.12
Volume (M$): $ 0 52 Wk Avg: $43.64
Open: $5.25 52 Wk Low: $0.54



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 0
 Employees 34
 Revenues (TTM) (Millions $) 3
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) 10
 Capital Exp. (TTM) (Millions $) 1

Business Description


Elevai Labs Inc is a technology company that specializes in artificial intelligence and machine learning solutions. They develop advanced algorithms and software tools for various industries, including healthcare, finance, and retail. Elevai Labs aims to provide organizations with cutting-edge AI technologies to automate processes, gain insights from data, and enhance decision-making capabilities. They focus on creating scalable and customizable solutions that can be integrated into existing systems seamlessly.


   Company Address: Graydon Bensler Newport Beach 92660 CA
   Company Phone Number: 445-4886   Stock Exchange / Ticker: NASDAQ ELAB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABUS        1.58% 
ASMB        7.43% 
CYCN        12.14% 
ENTA        3.53% 
PCRX        2.29% 
VRTX        0.82% 
• View Complete Report
   



Merger and Acquisition

PMGC Holdings Inc. Strengthens its Market Position with AGA Precision Systems LLC Acquisition,

Published Fri, Jul 18 2025 4:53 PM UTC

PMGC Holdings Inc. Expands Portfolio with Acquisition of AGA Precision Systems LLC Amid Strategic Corporate maneuversPMGC Holdings Inc. has announced a transformative step in its growth strategy with the recent acquisition of AGA Precision Systems LLC, a leading precision CNC machining company. This acquisition signifies a critical pivot in PMGC s approach to enhance its ope...

Stock Market Announcement

PMGC Holdings Inc. Positions for Growth with Skincare Subsidiary Sale and Strategic Share Exchange Offer through Elevai Labs Inc.

Published Thu, Jan 2 2025 8:55 PM UTC

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth StrategyIn a move that highlights its commitment to growth and innovation, PMGC Holdings Inc. has announced a strategic shift following the recent sale of its skincare subsidiary. The transaction, aimed at streamlining operations and enhancing overall corporate focus, aligns with the company’s e...

Merger and Acquisition

Carmell and PMGC Holdings Team Up to Acquire Elevai Skincare Amid Promising Advances in Obesity Treatment and AI Innovations

Published Thu, Jan 2 2025 1:01 PM UTC

In a transformative move for both the beauty and healthcare industries, Carmell and PMGC Holdings Inc. have officially announced the execution of a definitive agreement to acquire Elevai Skincare, a notable leader in physician-dispensed exosome skin and hair care products. This acquisition aligns with ongoing trends in personalized health solutions, focusing on innovative an...

Product Service News

The Next Frontier in Obesity Treatment Elevai Biosciences EL-22 Targets Fat Loss Amid Skepticism

Published Tue, Dec 31 2024 12:00 PM UTC

In an era marked by rising obesity rates and a relentless quest for effective weight-loss therapies, Elevai Biosciences, a subsidiary of Elevai Labs Inc. has announced a promising regulatory pathway for its innovative drug, EL-22. This pioneering therapy is designed not only to promote fat loss but also to prioritize muscle preservation, a critical aspect often overlooked in...

Clinical Study

Elevai Labs Pioneering the Future of Skincare and Hair Restoration with Exosome Technology

Published Wed, Oct 2 2024 12:31 PM UTC

The landscape of skincare is shifting dramatically with the emergence of advanced biotechnological innovations. Elevai Labs Inc. through its subsidiary Elevai Skincare Inc. is at the forefront of this transformation, leveraging proprietary exosome technology to redefine approaches to skin and hair health. Recent announcements regarding multiple clinical studies and the posit...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.99
Price to Sales (Expected) -
Price to Book 0.15
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.25
Working Capital Ratio 1.36
Leverage Ratio (MRQ) 1.18
Total Debt to Equity 0.54
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1633.29 $
Revenues (TTM) 5.29 $
Cash Flow (TTM) 19.92 $
Cash 39.22 $
Book Value 34.32 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 75,846
Net Income per Employee (TTM) -396,634
Receivable Turnover Ratio (TTM) 7.55
Inventory Turnover Ratio (TTM) 3.87
Asset Turnover Ratio (TTM) 0.11

Profitability Ratios Current
Gross Margin (MRQ) 21.01 %
Operating Margin (MRQ) 0 %
Net Margin (MRQ) -225.12 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Pmgc Holdings Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.